An engineered enzyme is at the center of a new method to visualize molecular details in human cells, and how these molecules change in cancerous versus benign cells, report Boston College researchers in the journal Cell Chemical Biology.
Engineered enzyme enables detailed mapping of tRNA changes in tumor cells
